TP53 and neoplasm: To address this, we performed somatic WGS analysis of 22 tumors (46 tumor regions) from childhood and young-adult patients [age 0–28, median age: 7.5] with confirmed pathogenic germline TP53 mutations (Fig. 1A, B; Data S1).